small molecule glp 1 agonist In patients with #obesity, incretin-based therapies such as GLP-1 receptor agonists are reported to result in mean weight reductions of approximately 15 to 20% along with additional health benefits, including decreased cardiovascular How GLP-1 Receptor Agonists Evolved

Mayendraraj, A., Rosenkilde, M

It may be useful in patients who have achieved their goal weight and are using lower doses to maintain their weight. However, early data and clinical experience suggest that it is an effective strategy, Orandi commented

What is the best time to inject GLP-1 drugs

15,19,22,23,31,32,38,39,41,43 TAKE-HOME MESSAGE Lifestyle modification remains the foundation of MASH management, 9 with weight loss of at least 10% associated with fibrosis regression in most patients

For context, only 4.2% of placebo participants achieved complete pain freedom

Also, weight-bearing exercise strengthens bones, making them denser and stronger